EXOG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.181000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.747600E-01
Normal-vs-Stage2
2.946800E-01
Normal-vs-Stage3
9.808000E-02
Normal-vs-Stage4
2.304600E-01
Stage1-vs-Stage2
1.795190E-01
Stage1-vs-Stage3
1.100580E-01
Stage1-vs-Stage4
3.112000E-01
Stage2-vs-Stage3
1.537570E-01
Stage2-vs-Stage4
9.312800E-01
Stage3-vs-Stage4
4.110400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.263400E-01
Normal-vs-AfricanAmerican
1.255400E-01
Normal-vs-Asian
2.571800E-01
Caucasian-vs-AfricanAmerican
8.791000E-01
Caucasian-vs-Asian
2.449200E-01
AfricanAmerican-vs-Asian
4.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.030800E-01
Normal-vs-Female
3.396200E-01
Male-vs-Female
2.977800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.652000E-01
Normal-vs-Age(41-60Yrs)
3.476400E-01
Normal-vs-Age(61-80Yrs)
3.002800E-01
Normal-vs-Age(81-100Yrs)
3.550100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.583600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.081000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.078000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.635190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.320400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.579200E-01
Normal-vs-Daily Drinker
2.723000E-01
Normal-vs-Weekly Drinker
3.464000E-01
Normal-vs-Occasional Drinker
3.007200E-01
Normal-vs-Social Drinker
7.898400E-02
Non Drinker-vs-Daily Drinker
7.471600E-01
Non Drinker-vs-Weekly Drinker
1.695210E-01
Non Drinker-vs-Occasional Drinker
4.595200E-01
Non Drinker-vs-Social Drinker
9.659600E-02
Daily Drinker-vs-Weekly Drinker
2.497000E-01
Daily Drinker-vs-Occasional Drinker
6.442600E-01
Daily Drinker-vs-Social Drinker
1.541220E-01
Weekly Drinker-vs-Occasional Drinker
5.486200E-01
Weekly Drinker-vs-Social Drinker
7.749400E-01
Occasional Drinker-vs-Social Drinker
3.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.814600E-01
Normal-vs-Grade 2
9.059600E-01
Normal-vs-Grade 3
9.722200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.907580E-01
Grade 1-vs-Grade 3
6.285800E-02
Grade 1-vs-Grade 4
5.814600E-01
Grade 2-vs-Grade 3
2.037200E-01
Grade 2-vs-Grade 4
9.059600E-01
Grade 3-vs-Grade 4
9.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.828800E-01
Normal-vs-NonDiabetic
3.131800E-01
Diabetic-vs-NonDiabetic
4.128600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.926400E-01
Normal-vs-NoPancreatitis
3.053400E-01
Pancreatitis-vs-NoPancreatitis
7.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.762400E-02
Normal-vs-N1
2.946800E-01
N0-vs-N1
9.808200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.330400E-01
Normal-vs-TP53-NonMutant
1.371370E-01
TP53-Mutant-vs-TP53-NonMutant
2.417100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
